BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
See today's BioWorld
Home
» Other news to note for Oct. 21, 2020
To read the full article
sign up for free
or
sign in
.
Other news to note for Oct. 21, 2020
Oct. 21, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Actinium, Arsenalbio, Astrazeneca, Biomx, Bridgebio, Cannabics, Chromotek, Cidara, Curelab, Curis, Diurnal, Effrx, Epsilogen, Hemoshear, GT, Intelgenx, Kintara, Moleculin, Mybiotics, Neoimmunetech, Neumentum, Noveome, Nuance (Shanghai), PCI, Poseida, Proteintech, Prothena, PTC, Roche, Scynexis, Seqirus, Takeda, Teneobio, Tetra Bio, Tscan, Union, Vir.
BioWorld
Briefs
Other news to note
Coronavirus